Meanwhile, across the country, members of the Los Angeles Pink Dragons, trained in the summer for the annual International Dragon Boat festival in Long Beach, California, held in July, and the 10 th ...

The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide develop cancer during their lifetime, and one in ...

Galleri, a blood test that aims to detect over 50 cancers, illustrates the promise and popularity of an emerging technology to screen for cancer. Although the blood test is not approved by the Food ...

“These updated recommendations will help to improve compliance with screening and reduce the risk of cervical cancer,” said Dr. Robert Smith, senior vice president, early cancer detection science at ...

The tool — CTS5 (Clinical Treatment Score post-5-years) — was developed with colleagues at The Royal Marsden NHS Foundation Trust and could be used to determine which patients are at high enough risk ...

Therapeutic vaccines train the immune system to recognize and attack malignant cells.

During chemotherapy, 29% of participants in the cooling group developed at least Grade 2 neuropathy in the frozen-glove hand, compared with 50% in the untreated hand. In the compression group, 24% had ...

Bishop Stacey Latimer, 63, was diagnosed with metastatic prostate cancer in 2019. He enrolled in a clinical trial and is still going strong.

Between the end of February and mid-August 2025, this first round of cuts to the NIH disrupted 383 studies testing treatments for cancer, heart disease, brain disease and more. In addition, of 11,008 ...

The original IV infusion formulation of Opdivo is approved for the treatment of 11 different types of cancer. The new injectable formulation is indicated—alone or in combination regimens—for most of ...

Akiko Hanai of Kyoto University and her colleagues studied peripheral neuropathy prevention in 40 women receiving paclitaxel for breast cancer. The average age was 56. The women wore Elasto-Gel frozen ...

A combination, triplet therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in nearly all patients with recurrent or persistent estrogen receptor- (ER-) ...